The growth inhibition effect of BSO on pad2-1 seemed however to reach a plateau at the highest dose, in contrast to Col-0
This ensures the correct pharmacokinetic release profile and minimizes free iron in the final formulation
In the rare event of an adverse reaction, kindly discontinue use
Patients were excluded if they took non-steroidal anti-inflammatory drugs (NSAIDs), any change in the dose, type, or frequency of DMARDs, consumed alcohol, had other autoimmune diseases, kidney disorders, pancreatitis, gallstones, or cancer, followed special diets in the past three months, or had recent medication changes
References: [1]Ford, Megan
Participants Thirty-three adults aged 20 to 60 (mean age 38.45) were enrolled, all presenting with self-assessed uneven skin tone and pigmentation